Understanding of the biology and clinical behavior of ductal carcinoma in situ (DCIS) is
currently inadequate. The aim of this comprehensive review was to identify important …

Inactivation of the p53 tumor suppressor is a frequent event in tumorigenesis. In most cases,
the p53 gene is mutated, giving rise to a stable mutant protein whose accumulation is …

Purpose The risk of local and regional relapse associated with each breast cancer
molecular subtype was determined in a large cohort of patients with breast cancer. Subtype …

Diagnosis and management of ductal carcinoma in situ (DCIS). - Abstract - Europe PMC Sign in
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

The objective of this review is to describe characteristic MR mammographic findings for
signal increase and morphological patterns of enhancement in pure ductal carcinoma in situ …

The optimal management of ductal carcinoma in situ (DCIS) is controversial, due in part to
our poor understanding of its natural history. We undertook to identify subgroups of DCIS …

BAG‐1 is a multifunctional and anti‐apoptotic or anti‐cell death protein that interacts with a
variety of cellular proteins and affects their functions. On the cell surface, it binds to the …

Eighteen percent of all new breast cancers detected on screening mammography are ductal
carcinoma in situ (DCIS), a preinvasive lesion that is highly curable. However, some women …

Precursors and preinvasive lesions of the breast include atypical ductal hyperplasia (ADH),
ductal carcinoma in situ (DCIS), and lobular neoplasia (LN). There is a significant debate …

Mammographic screening leads to frequent biopsies and concomitant overdiagnosis of
breast cancer, particularly ductal carcinoma in situ (DCIS). Some DCIS lesions rapidly …